OpenBilldrug price receipt

NADAC week of 2026-10-14

AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-320-25 MG TAB

For 30 tablets

Pharmacies pay

$163.30 filed

30 × $5.44347 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare

We don’t know yet

No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.


The spread

We don’t know yet

There is no Medicare figure to compare with, so there is no spread.

Cost-plus estimate

$192.80 estimated

$163.30 + $24.50 (15%) + $5.00 fee per fill = $192.80

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-320-25 MG TAB is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “amlodipine, valsartan and hydrochlorothiazide”, “amlodipine besylate valsartan hydrochlorothiazide” and “amlodipine,valsartan and hydrochlorothiazide”, as its NDCs’ listings variously write the nonproprietary name, under the trade name “AMLODIPINE, VALSARTAN, HYDROCHLOROTHIAZIDE”.

FDA gives its dosage form as tablet, film coated and its route as oral.

Its labelers, the companies named on the label, are Macleods Pharmaceuticals Limited, Strides Pharma Science Limited and Aurobindo Pharma Limited.

FDA lists it under 4 Established Pharmacologic Classes: Angiotensin 2 Receptor Blocker, Calcium Channel Blocker, Dihydropyridine Calcium Channel Blocker and Thiazide Diuretic.

The NADAC file of 2026-10-14 prices it under 3 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $163.30 for 30 tablets (30 × $5.44347 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

All 3 NDCs

Other strengths, forms and brands

4 other products in the NADAC file share an FDA nonproprietary name with AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-320-25 MG TAB.

ProductPharmacies pay per unitMedicare per unit
AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-12.5 MG TAB
generic · tablet, film coated
$4.8615 per EA filed
eff. 2026-09-23
We don’t know yet
AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-25 MG TAB
generic · tablet, film coated
$4.23865 per EA filed
eff. 2026-09-23
We don’t know yet
AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-12.5 MG TAB
generic · tablet, film coated
$4.9435 per EA filed
eff. 2026-09-23
We don’t know yet
AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-25 MG TAB
generic · tablet, film coated
$6.08879 per EA filed
eff. 2026-09-23
We don’t know yet
AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-320-25 MG TAB this page
generic · tablet, film coated
$5.44347 per EA filed
eff. 2026-09-23
We don’t know yet

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Compared with its class

The middle of its 3 NDCs’ NADAC prices is $5.44347 per EA filed.

Of the 107 other products in FDA’s Angiotensin 2 Receptor Blocker class priced per EA, 39 have a higher middle NADAC price and 68 a lower one. The one in the middle is CANDESARTAN-HYDROCHLOROTHIAZIDE 32-25 MG TAB, at $1.07781 per EA filed (eff. 2026-09-23).

Of the 107 other products in FDA’s Calcium Channel Blocker class priced per EA, 15 have a higher middle NADAC price and 92 a lower one. The one in the middle is OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-5-25 MG, at $0.99481 per EA filed (eff. 2026-09-23).

Of the 67 other products in FDA’s Dihydropyridine Calcium Channel Blocker class priced per EA, 12 have a higher middle NADAC price and 55 a lower one. The one in the middle is NICARDIPINE 20 MG CAPSULE, at $1.12012 per EA filed (eff. 2026-09-23).

Of the 68 other products in FDA’s Thiazide Diuretic class priced per EA, 11 have a higher middle NADAC price and 57 a lower one. The one in the middle is TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB, at $0.3567 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

We don’t know yet; the card above says why.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.